Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anterior Cruciate Ligament | 86 | 2024 | 415 | 15.630 |
Why?
|
Wound Healing | 48 | 2019 | 2781 | 4.980 |
Why?
|
Tissue Scaffolds | 30 | 2019 | 957 | 4.610 |
Why?
|
Knee Injuries | 20 | 2024 | 490 | 4.400 |
Why?
|
Platelet-Rich Plasma | 18 | 2024 | 177 | 4.140 |
Why?
|
Collagen | 35 | 2022 | 2684 | 3.990 |
Why?
|
Knee Joint | 29 | 2023 | 1679 | 3.520 |
Why?
|
Cartilage, Articular | 14 | 2023 | 1095 | 2.880 |
Why?
|
Osteoarthritis | 9 | 2023 | 1034 | 2.790 |
Why?
|
Fibroblasts | 23 | 2013 | 4143 | 2.410 |
Why?
|
Swine | 50 | 2023 | 5934 | 2.410 |
Why?
|
Synovial Membrane | 9 | 2023 | 506 | 2.390 |
Why?
|
Swine, Miniature | 26 | 2023 | 961 | 2.030 |
Why?
|
Blood Platelets | 15 | 2015 | 2506 | 1.920 |
Why?
|
Sterilization | 4 | 2021 | 134 | 1.910 |
Why?
|
Extracellular Matrix | 11 | 2022 | 1740 | 1.620 |
Why?
|
Tissue Engineering | 13 | 2015 | 1877 | 1.430 |
Why?
|
Hydrogels | 6 | 2022 | 723 | 1.340 |
Why?
|
Synovitis | 2 | 2023 | 209 | 1.320 |
Why?
|
Device Approval | 2 | 2022 | 163 | 1.180 |
Why?
|
Collagen Type I | 6 | 2015 | 592 | 1.140 |
Why?
|
Suture Techniques | 5 | 2015 | 797 | 1.040 |
Why?
|
Collagen Type III | 5 | 2013 | 90 | 1.030 |
Why?
|
Platelet Transfusion | 4 | 2012 | 314 | 0.950 |
Why?
|
Tibia | 11 | 2022 | 1075 | 0.930 |
Why?
|
Weight-Bearing | 8 | 2015 | 514 | 0.900 |
Why?
|
Osteoarthritis, Knee | 6 | 2024 | 1222 | 0.890 |
Why?
|
Models, Animal | 13 | 2015 | 2170 | 0.860 |
Why?
|
Animals | 84 | 2023 | 168561 | 0.850 |
Why?
|
Leukocytes, Mononuclear | 3 | 2012 | 1835 | 0.760 |
Why?
|
Nitrogen | 1 | 2021 | 343 | 0.740 |
Why?
|
Cattle | 11 | 2021 | 3923 | 0.710 |
Why?
|
Platelet Activation | 4 | 2011 | 671 | 0.670 |
Why?
|
Sutures | 4 | 2015 | 298 | 0.660 |
Why?
|
Chondrogenesis | 1 | 2020 | 247 | 0.640 |
Why?
|
Joint Instability | 7 | 2012 | 792 | 0.630 |
Why?
|
Orthopedic Procedures | 7 | 2013 | 1288 | 0.620 |
Why?
|
Sus scrofa | 7 | 2015 | 437 | 0.620 |
Why?
|
Thrombin | 3 | 2011 | 598 | 0.610 |
Why?
|
Femur | 7 | 2021 | 1297 | 0.600 |
Why?
|
Stifle | 4 | 2012 | 28 | 0.590 |
Why?
|
Cell Movement | 7 | 2012 | 5212 | 0.550 |
Why?
|
Triamcinolone Acetonide | 1 | 2016 | 101 | 0.540 |
Why?
|
Mesenchymal Stem Cells | 4 | 2014 | 1625 | 0.530 |
Why?
|
Ethylene Oxide | 1 | 2015 | 27 | 0.530 |
Why?
|
Menisci, Tibial | 5 | 2024 | 269 | 0.520 |
Why?
|
Injections, Intra-Articular | 5 | 2024 | 278 | 0.500 |
Why?
|
Hindlimb | 5 | 2019 | 505 | 0.500 |
Why?
|
Guided Tissue Regeneration | 2 | 2013 | 85 | 0.480 |
Why?
|
Decorin | 1 | 2014 | 40 | 0.480 |
Why?
|
Tenascin | 1 | 2014 | 59 | 0.470 |
Why?
|
Rotator Cuff | 2 | 2015 | 324 | 0.470 |
Why?
|
Regeneration | 5 | 2015 | 1485 | 0.450 |
Why?
|
Biological Products | 1 | 2022 | 856 | 0.450 |
Why?
|
Ligaments | 2 | 2014 | 127 | 0.440 |
Why?
|
Bone Development | 3 | 2011 | 483 | 0.440 |
Why?
|
Polyglactin 910 | 1 | 2012 | 59 | 0.440 |
Why?
|
Polyethylene Terephthalates | 1 | 2012 | 116 | 0.430 |
Why?
|
Platelet-Derived Growth Factor | 4 | 2011 | 625 | 0.430 |
Why?
|
Fibrillar Collagens | 1 | 2012 | 41 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 23 | 2023 | 35342 | 0.420 |
Why?
|
Plasma | 1 | 2015 | 575 | 0.420 |
Why?
|
Random Allocation | 6 | 2015 | 2425 | 0.410 |
Why?
|
Transforming Growth Factor beta1 | 5 | 2011 | 644 | 0.410 |
Why?
|
alpha-Galactosidase | 1 | 2011 | 57 | 0.400 |
Why?
|
Proteome | 2 | 2019 | 1790 | 0.390 |
Why?
|
Bone Transplantation | 3 | 2011 | 907 | 0.380 |
Why?
|
Growth Plate | 1 | 2012 | 274 | 0.380 |
Why?
|
Cells, Cultured | 16 | 2013 | 19223 | 0.380 |
Why?
|
Chondrocytes | 4 | 2021 | 803 | 0.370 |
Why?
|
Medial Collateral Ligament, Knee | 2 | 2007 | 25 | 0.360 |
Why?
|
Erythrocytes | 2 | 2011 | 2452 | 0.360 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2010 | 180 | 0.360 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2010 | 185 | 0.350 |
Why?
|
Extracellular Matrix Proteins | 2 | 2013 | 849 | 0.350 |
Why?
|
Cell Count | 3 | 2021 | 1831 | 0.350 |
Why?
|
Surface-Active Agents | 1 | 2009 | 158 | 0.340 |
Why?
|
Sheep | 5 | 2015 | 1437 | 0.340 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2010 | 314 | 0.330 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 867 | 0.330 |
Why?
|
Rupture | 6 | 2014 | 430 | 0.330 |
Why?
|
Tissue Adhesives | 1 | 2010 | 179 | 0.330 |
Why?
|
Athletic Injuries | 3 | 2019 | 1153 | 0.320 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 544 | 0.310 |
Why?
|
Knee Prosthesis | 1 | 2011 | 425 | 0.310 |
Why?
|
Tendon Injuries | 1 | 2011 | 313 | 0.310 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 552 | 0.310 |
Why?
|
Disease Models, Animal | 13 | 2019 | 18006 | 0.300 |
Why?
|
Gene Expression Profiling | 4 | 2023 | 9410 | 0.300 |
Why?
|
Transforming Growth Factor beta | 4 | 2004 | 2006 | 0.300 |
Why?
|
Actins | 8 | 2004 | 2120 | 0.300 |
Why?
|
Fibrin | 1 | 2010 | 506 | 0.300 |
Why?
|
Tensile Strength | 3 | 2013 | 334 | 0.290 |
Why?
|
Cell Culture Techniques | 3 | 2010 | 1670 | 0.290 |
Why?
|
Connective Tissue | 1 | 2009 | 420 | 0.290 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2010 | 664 | 0.290 |
Why?
|
Glucocorticoids | 1 | 2016 | 2107 | 0.290 |
Why?
|
Postoperative Complications | 5 | 2017 | 15244 | 0.290 |
Why?
|
Gene Expression Regulation | 4 | 2013 | 12071 | 0.270 |
Why?
|
Matrix Metalloproteinase 1 | 3 | 2017 | 141 | 0.270 |
Why?
|
Muscle Strength | 2 | 2020 | 586 | 0.260 |
Why?
|
Dogs | 5 | 2011 | 3910 | 0.260 |
Why?
|
Transgenes | 2 | 2010 | 1009 | 0.260 |
Why?
|
Tendons | 2 | 2009 | 548 | 0.260 |
Why?
|
Cell Proliferation | 9 | 2012 | 10472 | 0.260 |
Why?
|
Blood Proteins | 1 | 2010 | 1122 | 0.250 |
Why?
|
Transplantation, Homologous | 3 | 2013 | 4771 | 0.250 |
Why?
|
Synovial Fluid | 3 | 2022 | 394 | 0.250 |
Why?
|
Cytokines | 2 | 2011 | 7317 | 0.250 |
Why?
|
Biocompatible Materials | 2 | 2011 | 1731 | 0.250 |
Why?
|
Cryopreservation | 1 | 2009 | 664 | 0.240 |
Why?
|
Fractures, Cartilage | 1 | 2004 | 22 | 0.240 |
Why?
|
Age Factors | 8 | 2012 | 18355 | 0.240 |
Why?
|
Polyethylene Glycols | 1 | 2009 | 1181 | 0.240 |
Why?
|
Rats, Inbred Lew | 3 | 2021 | 1161 | 0.230 |
Why?
|
Patellar Ligament | 2 | 2015 | 60 | 0.230 |
Why?
|
Matrix Metalloproteinase 13 | 2 | 2014 | 103 | 0.230 |
Why?
|
Macrophages | 2 | 2015 | 5655 | 0.230 |
Why?
|
Hemostatics | 1 | 2006 | 229 | 0.230 |
Why?
|
Female | 48 | 2024 | 379592 | 0.220 |
Why?
|
Goats | 3 | 2011 | 172 | 0.220 |
Why?
|
Linear Models | 6 | 2019 | 5948 | 0.220 |
Why?
|
Temperature | 1 | 2009 | 2207 | 0.220 |
Why?
|
Transduction, Genetic | 2 | 2010 | 913 | 0.210 |
Why?
|
RNA, Messenger | 4 | 2014 | 13029 | 0.210 |
Why?
|
Male | 43 | 2024 | 349538 | 0.200 |
Why?
|
Powders | 1 | 2021 | 80 | 0.200 |
Why?
|
Humans | 61 | 2024 | 742088 | 0.200 |
Why?
|
Guinea Pigs | 1 | 2022 | 1386 | 0.190 |
Why?
|
Aging | 5 | 2011 | 8626 | 0.190 |
Why?
|
Glycosaminoglycans | 2 | 2001 | 624 | 0.190 |
Why?
|
Materials Testing | 3 | 2012 | 865 | 0.190 |
Why?
|
Adipose Tissue | 1 | 2012 | 3278 | 0.180 |
Why?
|
Gamma Rays | 1 | 2021 | 320 | 0.180 |
Why?
|
Transplantation, Autologous | 3 | 2021 | 2123 | 0.180 |
Why?
|
Technology | 1 | 2022 | 303 | 0.180 |
Why?
|
Rats | 6 | 2021 | 24265 | 0.180 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2007 | 2014 | 0.170 |
Why?
|
Equipment and Supplies | 1 | 2022 | 281 | 0.170 |
Why?
|
Treatment Outcome | 11 | 2024 | 62966 | 0.170 |
Why?
|
Models, Biological | 3 | 2017 | 9581 | 0.160 |
Why?
|
Coculture Techniques | 2 | 2012 | 1341 | 0.160 |
Why?
|
Gene Expression | 5 | 2012 | 7790 | 0.160 |
Why?
|
Rheology | 2 | 2009 | 345 | 0.160 |
Why?
|
Cell Survival | 4 | 2021 | 5872 | 0.160 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2022 | 430 | 0.150 |
Why?
|
Gels | 2 | 2010 | 427 | 0.150 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 144 | 0.150 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 581 | 0.150 |
Why?
|
Time Factors | 8 | 2016 | 40054 | 0.150 |
Why?
|
Analysis of Variance | 5 | 2013 | 6365 | 0.150 |
Why?
|
Adolescent | 14 | 2024 | 85649 | 0.150 |
Why?
|
Collagen Type II | 2 | 2017 | 151 | 0.150 |
Why?
|
Cell Division | 3 | 2011 | 4564 | 0.140 |
Why?
|
Species Specificity | 2 | 2011 | 2479 | 0.140 |
Why?
|
DNA Fragmentation | 2 | 2006 | 242 | 0.130 |
Why?
|
Talus | 2 | 2006 | 72 | 0.130 |
Why?
|
Culture Media | 2 | 2010 | 902 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2010 | 11363 | 0.120 |
Why?
|
Orthopedics | 1 | 2023 | 903 | 0.120 |
Why?
|
Radiography | 4 | 2019 | 7010 | 0.120 |
Why?
|
Elastic Modulus | 1 | 2015 | 213 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2020 | 996 | 0.120 |
Why?
|
United States Food and Drug Administration | 1 | 2022 | 1581 | 0.120 |
Why?
|
Adenoviridae | 3 | 2010 | 1096 | 0.120 |
Why?
|
In Situ Nick-End Labeling | 2 | 2006 | 643 | 0.120 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2013 | 19 | 0.120 |
Why?
|
Blood | 2 | 2015 | 598 | 0.120 |
Why?
|
Electrons | 1 | 2015 | 268 | 0.120 |
Why?
|
Aggrecans | 1 | 2013 | 90 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 8925 | 0.120 |
Why?
|
Posterior Cruciate Ligament | 1 | 2014 | 88 | 0.120 |
Why?
|
Radiation Dosage | 1 | 2021 | 1927 | 0.110 |
Why?
|
Recovery of Function | 2 | 2015 | 2924 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4751 | 0.110 |
Why?
|
Joints | 1 | 2014 | 326 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1999 | 1504 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 886 | 0.100 |
Why?
|
ADAM Proteins | 1 | 2013 | 242 | 0.100 |
Why?
|
DNA | 3 | 2011 | 7289 | 0.100 |
Why?
|
Young Adult | 8 | 2024 | 56350 | 0.100 |
Why?
|
Elasticity | 3 | 2009 | 657 | 0.100 |
Why?
|
Cold Temperature | 1 | 2015 | 774 | 0.100 |
Why?
|
Athletes | 1 | 2019 | 1092 | 0.100 |
Why?
|
Treatment Failure | 1 | 2017 | 2615 | 0.100 |
Why?
|
Regenerative Medicine | 1 | 2015 | 306 | 0.100 |
Why?
|
Apoptosis | 3 | 2013 | 9715 | 0.100 |
Why?
|
Leg Length Inequality | 1 | 2011 | 55 | 0.100 |
Why?
|
Metabolism | 1 | 2012 | 193 | 0.100 |
Why?
|
Culture Media, Conditioned | 1 | 2012 | 533 | 0.100 |
Why?
|
Growth Differentiation Factor 6 | 1 | 2010 | 8 | 0.100 |
Why?
|
Diffusion Chambers, Culture | 1 | 2010 | 50 | 0.090 |
Why?
|
Procollagen | 1 | 2011 | 185 | 0.090 |
Why?
|
Cell Differentiation | 4 | 2012 | 11470 | 0.090 |
Why?
|
Absorbable Implants | 1 | 2012 | 342 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1675 | 0.090 |
Why?
|
Epiphyses | 1 | 2011 | 189 | 0.090 |
Why?
|
Equipment Failure | 1 | 2012 | 579 | 0.090 |
Why?
|
Immunoenzyme Techniques | 2 | 2006 | 1799 | 0.090 |
Why?
|
Suture Anchors | 1 | 2010 | 78 | 0.090 |
Why?
|
Hemorheology | 1 | 2010 | 145 | 0.090 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2009 | 131 | 0.090 |
Why?
|
Adult | 18 | 2024 | 213712 | 0.090 |
Why?
|
Growth Differentiation Factors | 1 | 2010 | 98 | 0.090 |
Why?
|
Prospective Studies | 7 | 2023 | 53187 | 0.090 |
Why?
|
Protein Denaturation | 1 | 2009 | 237 | 0.080 |
Why?
|
Periosteum | 1 | 2009 | 138 | 0.080 |
Why?
|
Cell Shape | 1 | 2010 | 375 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1213 | 0.080 |
Why?
|
Reoperation | 3 | 2023 | 4200 | 0.080 |
Why?
|
Ligaments, Articular | 1 | 2011 | 298 | 0.080 |
Why?
|
Awards and Prizes | 1 | 2013 | 375 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3502 | 0.080 |
Why?
|
Platelet Count | 1 | 2011 | 780 | 0.080 |
Why?
|
Capillaries | 1 | 2011 | 774 | 0.080 |
Why?
|
Single-Blind Method | 1 | 2012 | 1589 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 926 | 0.080 |
Why?
|
Range of Motion, Articular | 2 | 2011 | 1577 | 0.070 |
Why?
|
Rabbits | 2 | 2011 | 4886 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1801 | 0.070 |
Why?
|
Muscle, Smooth | 2 | 2001 | 933 | 0.070 |
Why?
|
Injections | 1 | 2009 | 840 | 0.070 |
Why?
|
Body Temperature | 1 | 2009 | 776 | 0.070 |
Why?
|
Femoral Fractures | 1 | 2009 | 376 | 0.070 |
Why?
|
Bone Nails | 1 | 2007 | 219 | 0.070 |
Why?
|
Parents | 1 | 2019 | 3387 | 0.070 |
Why?
|
Transplants | 1 | 2008 | 208 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 838 | 0.060 |
Why?
|
In Situ Hybridization | 1 | 2009 | 1950 | 0.060 |
Why?
|
Epitopes | 1 | 2011 | 2569 | 0.060 |
Why?
|
Sports | 1 | 2011 | 686 | 0.060 |
Why?
|
Arthroscopy | 1 | 2011 | 924 | 0.060 |
Why?
|
Fracture Fixation | 1 | 2007 | 354 | 0.060 |
Why?
|
Bone Cysts | 1 | 2004 | 47 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2614 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4211 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1188 | 0.060 |
Why?
|
Humeral Fractures | 1 | 2007 | 272 | 0.060 |
Why?
|
X-Ray Microtomography | 2 | 2016 | 428 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39004 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2010 | 2372 | 0.060 |
Why?
|
Gait | 2 | 2022 | 784 | 0.060 |
Why?
|
Risk Factors | 4 | 2022 | 72145 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3465 | 0.060 |
Why?
|
United States | 3 | 2023 | 69693 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2022 | 19862 | 0.060 |
Why?
|
Amino Acids | 1 | 2009 | 1727 | 0.060 |
Why?
|
Embryo, Mammalian | 1 | 2009 | 1692 | 0.060 |
Why?
|
Monocytes | 1 | 2012 | 2593 | 0.050 |
Why?
|
Foreign Bodies | 1 | 2006 | 398 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3199 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5975 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 317 | 0.050 |
Why?
|
Sex Factors | 1 | 2015 | 10392 | 0.050 |
Why?
|
Lead | 1 | 2006 | 854 | 0.050 |
Why?
|
Biodegradation, Environmental | 1 | 2001 | 219 | 0.050 |
Why?
|
Cell Line | 1 | 2015 | 15994 | 0.050 |
Why?
|
Cicatrix | 1 | 2007 | 761 | 0.050 |
Why?
|
Chondroitin ABC Lyase | 1 | 2000 | 17 | 0.050 |
Why?
|
Wounds, Gunshot | 1 | 2006 | 562 | 0.050 |
Why?
|
Child | 6 | 2024 | 77478 | 0.050 |
Why?
|
Hyaluronic Acid | 1 | 2024 | 489 | 0.050 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2000 | 133 | 0.050 |
Why?
|
Normal Distribution | 1 | 2020 | 280 | 0.050 |
Why?
|
Collagenases | 1 | 2000 | 228 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2011 | 2896 | 0.040 |
Why?
|
Culture Techniques | 1 | 2000 | 554 | 0.040 |
Why?
|
Trypsin | 1 | 2000 | 509 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3469 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2021 | 644 | 0.040 |
Why?
|
Middle Aged | 12 | 2019 | 213127 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3611 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 2088 | 0.040 |
Why?
|
Stress, Mechanical | 3 | 2013 | 1684 | 0.040 |
Why?
|
Cartilage | 1 | 2022 | 818 | 0.040 |
Why?
|
Cell Death | 1 | 2004 | 1695 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 40450 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12242 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2022 | 21719 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.030 |
Why?
|
Aged | 8 | 2010 | 162944 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 24913 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2968 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 7901 | 0.030 |
Why?
|
Incidence | 1 | 2013 | 20928 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2006 | 1945 | 0.030 |
Why?
|
Leadership | 1 | 2023 | 1357 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1839 | 0.030 |
Why?
|
Bone Demineralization Technique | 1 | 2013 | 26 | 0.030 |
Why?
|
Protein Isoforms | 1 | 1999 | 1727 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2014 | 379 | 0.030 |
Why?
|
Choice Behavior | 1 | 2019 | 802 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2000 | 1350 | 0.030 |
Why?
|
Blood Vessels | 1 | 1999 | 1124 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2303 | 0.030 |
Why?
|
Logistic Models | 1 | 2006 | 13403 | 0.030 |
Why?
|
Osteonecrosis | 1 | 2013 | 227 | 0.020 |
Why?
|
Teriparatide | 1 | 2013 | 225 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 977 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3937 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2020 | 2585 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2024 | 77098 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2004 | 57683 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2001 | 2400 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1157 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15194 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2013 | 1801 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1989 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 774 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3215 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14720 | 0.020 |
Why?
|
Chelating Agents | 1 | 2006 | 380 | 0.020 |
Why?
|
Foot Injuries | 1 | 2006 | 148 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 3139 | 0.010 |
Why?
|
Spinal Fusion | 1 | 2013 | 1234 | 0.010 |
Why?
|
Blotting, Western | 2 | 2001 | 5180 | 0.010 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2003 | 75 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2013 | 3584 | 0.010 |
Why?
|
Infant | 1 | 2023 | 35070 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3420 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6191 | 0.010 |
Why?
|
Ankle Injuries | 1 | 2004 | 331 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4029 | 0.010 |
Why?
|
Proteins | 1 | 2014 | 6096 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 12730 | 0.010 |
Why?
|
Bone and Bones | 1 | 2008 | 2575 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3328 | 0.010 |
Why?
|
Arthroplasty, Replacement | 1 | 2000 | 336 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2000 | 1372 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13853 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6608 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 40955 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2004 | 20086 | 0.000 |
Why?
|